The views expressed in this article are those of the writer and not necessarily those of Breaking Belize News.
By Dorian A. Barrow, Ph.D.
Florida State University
As my old high school English teacher, Dr. Sir Colville Young, used to remind us, words matter. “Worst,” he would say, is the superlative of bad—the lowest, most unfavorable, most severe condition imaginable. “Better,” by contrast, implies improvement, progress, and a movement toward something more desirable. Today, as Belize stands on the brink of the full rollout of the National Health Insurance (NHI) program, his lesson feels more relevant than ever. Is this sweeping reform for the better—or for the worse? The answer, as with many national questions, depends very much on where you stand.
For the ordinary Belizean—particularly the elderly—the NHI promises relief. Imagine a 74-year-old man, long past retirement age but still working because he cannot afford not to. For him, healthcare is not an abstract policy issue; it is a daily concern tied to survival. Doctor visits, medication, lab tests—these are not luxuries but necessities. In such a context, the NHI represents something undeniably positive: access. It offers reduced out-of-pocket expenses, more predictable care, and perhaps even a sense of dignity in old age. For people like him, the program is not merely “better”—it is essential.
Yet, shift your perspective slightly, and the picture begins to change. Consider the small, independent pharmacy owner—someone like Roy Stanley Gill of Alfa-Drugs. For decades, these pharmacies have served their communities, often extending credit, offering advice, and functioning as informal pillars of neighborhood healthcare. But to them, the NHI rollout feels less like progress and more like a slow and terrifying death. Why? Because the system appears to centralize power and purchasing within NHI-approved clinics and their affiliated pharmacies.
When patients are funneled into NHI clinics—where consultations, prescriptions, and drug dispensing all occur under one roof—independent pharmacies are effectively cut out of the loop. The playing field is no longer level. Small businesses, already operating on thin margins, now face an existential threat. From their vantage point, the NHI is not a reform but a racket, one that consolidates control while eroding competition. For them, “worse” may not even capture the full gravity of the situation.
Then there is yet another perspective—perhaps the most unsettling of all. Within Belize exists a small but powerful network of pharmaceutical suppliers, sometimes described—fairly or unfairly—as a “cabal.” For these actors, the NHI represents not a threat but an opportunity. With centralized procurement and large-scale government contracts, the financial stakes are enormous. To them, the NHI may well be the biggest gravy train in recent memory, a system ripe for profit, influence, and control over the national drug supply chain.
If this assessment holds even a kernel of truth, then the implications are troubling. A healthcare system designed to serve the public good risks becoming entangled with private interests in ways that may not always align with transparency or equity. In such a scenario, the benefits enjoyed by patients could come at a hidden cost—one borne by taxpayers, small businesses, and the integrity of the system itself.
Adding another layer to this unfolding situation is recent legislation requiring prescriptions for many medications that were previously available over the counter. On the surface, this could be framed as a public health measure—ensuring proper medical oversight and reducing misuse. But in practice, it has raised eyebrows across the country.
The requirement now extends to items such as oral contraceptives and even nebulizers—essential tools for family planning and asthma management, respectively. For many Belizeans, this shift feels not only inconvenient but excessive. It places additional burdens on individuals who must now visit a doctor—often at an NHI clinic—before accessing medications they once obtained easily and affordably.
Here is where the issue becomes particularly complex. Coincidentally—or perhaps not—all NHI clinics are equipped with their own pharmacies. The process is streamlined: you visit the clinic, receive a prescription, and fill it immediately on-site. From an efficiency standpoint, this is admirable. But from a competitive and ethical standpoint, it raises important questions. Are patients being guided toward a system that limits their choices? Are independent providers being sidelined in favor of a centralized model?
To some, this integration represents the future of healthcare—coordinated, efficient, and patient-centered. To others, it looks suspiciously like a closed loop, one that concentrates power and reduces transparency.
So where does this leave the average Belizean trying to decide whether the NHI rollout is for better or worse?
The truth is it is both.
It is better for those who have long been underserved—who can now access care without the crushing weight of medical bills. It is better for public health outcomes, at least in theory, as more people engage with formal healthcare systems. It is better in its intention: to create a more equitable society where healthcare is a right, not a privilege.
But it is also worse for small business owners who find themselves edged out of a system they helped sustain. It is worse if it fosters monopolistic tendencies or enables profiteering under the guise of reform. It is worse if it restricts access in subtle ways—by adding bureaucratic hurdles or limiting consumer choice.
Ultimately, the success or failure of the NHI will depend not on its design alone but on its implementation. Transparency, accountability, and inclusivity will be key. Policymakers must ensure that the system does not become a vehicle for exclusion or exploitation. Safeguards must be put in place to protect small businesses, prevent corruption, and maintain public trust.
Belize stands at a crossroads. The NHI rollout is not just a policy shift; it is a test of national priorities. Will the country choose a path that truly serves the many, or will it inadvertently benefit the few? Will it be a story of progress—or a cautionary tale?
As Dr. Young might say, the difference between “better” and “worst” is not merely semantic. It is a matter of outcome. And while that outcome is still being written, much more consultations are needed, especially with the Pharmaceutical Association and the owners of those small neighborhood pharmacists like Roy Stanley Gill.
Feel free to challenge any or all of the claims made in this piece and let us broaden our discussion on the NHI.
The post Point and Counterpoint~The NHI Full Rollout in Belize: For Better or Worse? appeared first on Belize News and Opinion on www.breakingbelizenews.com.
The views expressed in this article are those of the writer and not necessarily those of Breaking Belize News. By Dorian A. Barrow, Ph.D. Florida State University As my old high school English teacher, Dr. Sir Colville Young, used to remind us, words matter. “Worst,” he would say, is the superlative of bad—the lowest, most
The post Point and Counterpoint~The NHI Full Rollout in Belize: For Better or Worse? appeared first on Belize News and Opinion on www.breakingbelizenews.com.
